Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Mercury can disrupt sex hormones and cause reproductive issues.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Human skin cells can respond to thyroid-stimulating hormone, affecting hair and skin health.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

The CRH/CRH-R1 system might be involved in causing lichen planus.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.